Filana Therapeutics Inc.
FLNA | NASDAQ
$0.57
-$0.05 (-8.36%)
Nov 2, 2026, 1:43 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|
Net Income | -55.35M | -46.75M | -61.81M | -78.94M | -55.54M | -27.94M |
Depreciation & Amortization | 1.02M | 718K | 611K | 739K | 519K | 259K |
Stock-Based Compensation | 4.4M | 4.4M | 10.15M | 11.35M | 11.35M | 5.61M |
Other Working Capital | 4.69M | 4.36M | 8.1M | 15.09M | 9.01M | 4.09M |
Other Non-Cash Items | 14.61M | 10.6M | 5.23M | 5.23M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.16M | 3.73M | -33M | -29.27M | -35.89M | 3.78M |
Operating Cash Flow | -31.16M | -27.31M | -78.82M | -90.9M | -79.56M | -18.3M |
Capital Expenditures | -602K | -581K | -137K | -74K | -74K | -17K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -602K | -581K | -137K | -74K | -74K | -17K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -16K | n/a | 918K | 918K | 918K | n/a |
Financial Cash Flow | -255K | -239K | 1.01M | 1.01M | 918K | n/a |
Net Cash Flow | -32.02M | -28.13M | -77.95M | -89.96M | -78.72M | -18.31M |
Free Cash Flow | -31.76M | -27.89M | -78.96M | -90.97M | -79.64M | -18.31M |
Adj. Free Cash Flow | -36.16M | -32.29M | -89.11M | -102.32M | -90.99M | -23.92M |
Maintenance CapEx | -468K | -504K | -154K | n/a | n/a | n/a |
Growth CapEx | -134K | -134K | n/a | n/a | n/a | n/a |
Owner Earnings | -31.63M | -89.07M | -97.27M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove FLNA